Ring Therapeutics
Ring Therapeutics is a Cambridge, Massachusetts biotechnology company founded by Flagship Pioneering that develops targeted vector conjugate medicines built on the human commensal virome. Its Anellogy platform harnesses anelloviruses — commensal viruses that co-exist with the human immune system — to generate gene delivery vectors with tissue-specific tropism and the potential to be redosed. Ring has sequenced thousands of anelloviruses into what it describes as the largest anellovirus database assembled to date, and has raised more than $250 million across Series A, B and C financings. The company is a therapeutics developer rather than a software provider: it publishes a corporate site, a press release stream and a scientific publications list, and operates no public API, developer portal or SDK.
Ring Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Gene Therapy, Life Sciences, and Pharmaceuticals.
Ring Therapeutics’ developer surface includes product news, engineering blog, and 12 more developer resources.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Agent Surfaces 1
MCP servers, agent skills, and machine-readable catalogs
Build 1
SDKs, sample code, and the tooling you integrate with
Access & Security 1
Authentication, authorization, and security posture
Operate 1
Status, limits, changes, and where to get help
Commercial 2
Pricing, plans, and the legal terms of use
Company 7
The organization behind the API
Scroll for all 7
Other 1
Properties that don't map to a standard resource type